In a patient experiencing hair loss attributed to propranolol, what is an appropriate alternative medication for the somatic (physical) symptoms of anxiety?

Alternative to Propranolol for Physical Anxiety Symptoms

Switch to an SSRI (escitalopram or sertraline) as first-line treatment, as beta-blockers like propranolol lack robust evidence for anxiety disorders and are explicitly deprecated in current guidelines. 1

Why Not Continue Beta-Blockers

The 2023 Japanese/Canadian guidelines specifically deprecate propranolol and atenolol for anxiety disorders based on negative evidence 1. This recommendation is supported by the most recent 2025 systematic review showing no beneficial effect of beta-blockers compared to placebo or benzodiazepines in social phobia or panic disorder (p ≥ 0.54 for all comparisons) 2. The 2016 meta-analysis similarly concluded there is insufficient evidence to support routine use of propranolol in any anxiety disorder 3.

While older studies (1974-1991) suggested propranolol might help with somatic anxiety symptoms 4, 5, 6, these findings have not been replicated in modern, adequately powered trials. The evidence base consists primarily of small studies with high risk of bias 2.

Recommended Alternative: SSRIs

First-line pharmacotherapy should be escitalopram or sertraline 1. These medications:

• Are recommended by NICE, S3, and Canadian guidelines as standard first-line agents
• Treat both psychological and somatic manifestations of anxiety
• Have robust evidence from multiple RCTs
• Are covered by insurance and cost-effective (approximately ¥30-300 per day) 1

Second-line options include fluvoxamine, paroxetine, or venlafaxine (SNRI), though these may have more side effects or discontinuation symptoms 1.

Addressing the Hair Loss Concern

Interestingly, recent evidence suggests propranolol may actually prevent stress-induced hair loss rather than cause it. A 2024 trial found topical propranolol reduced hair loss in 14/20 volunteers (p < 0.05) 7. If hair loss is occurring with oral propranolol, this is likely:

• Coincidental stress-related telogen effluvium (which the anxiety itself could cause)
• An idiosyncratic reaction requiring drug discontinuation regardless
• Not a class effect that would occur with SSRIs

Clinical Algorithm

1. Discontinue propranolol (taper if on high doses to avoid rebound tachycardia)
2. Initiate escitalopram 10 mg daily or sertraline 50 mg daily
3. Titrate after 2-4 weeks based on response (escitalopram up to 20 mg, sertraline up to 200 mg)
4. Monitor for 4-6 weeks for full anxiolytic effect
5. If inadequate response, switch to another SSRI or add venlafaxine 1

Important Caveats

• Avoid benzodiazepines for chronic use due to dependence risk; reserve only for acute situations requiring sedation 6
• SSRIs may initially increase anxiety in the first 1-2 weeks before improvement occurs
• For performance anxiety specifically (stage fright), propranolol 20-40 mg as-needed remains reasonable 6, 8, but this is distinct from treating generalized anxiety disorder
• Beta-blockers should be used cautiously in patients prone to depression 9

The evidence strongly favors moving away from propranolol to evidence-based first-line agents that address the full spectrum of anxiety symptoms, not just peripheral somatic manifestations.